Shawn Cross
Chief Financial OfficeratPacira BioSciences· In the 2024 proxy
Pay in FY2024Pacira BioSciences stock -44.2% the same year
Shawn Cross was paid $2.7M in FY2024 (Dec). Pacira BioSciences stock fell 44.2% that year.
Pay$100 in the stock at the end of FY23 → $56
Experience
- Pacira BioSciencesPublic company · 2 yr
- Chief Financial Officer2024 – Present · 2 yrStock in role +8%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?